share_log

微創機器人-B：董事名單及其角色和職能

MEDBOT-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

香港交易所 ·  Dec 29, 2023 05:46
Summary by Moomoo AI
上海微創醫療機器人（集團）股份有限公司（「微創機器人」）於2023年12月29日公布了董事會成員名單及其在董事會下設的四個委員會中的角色和職能。執行董事包括何超博士，非執行董事有孫洪斌先生、陳新星先生和陳琛先生。獨立非執行董事則包括李明華博士、姚海嵩先生和梅永康先生。委員會分別為審計委員會、薪酬與考核委員會、提名委員會以及戰略與發展委員會，各委員會成員的職位也在公告中得到確認。
上海微創醫療機器人（集團）股份有限公司（「微創機器人」）於2023年12月29日公布了董事會成員名單及其在董事會下設的四個委員會中的角色和職能。執行董事包括何超博士，非執行董事有孫洪斌先生、陳新星先生和陳琛先生。獨立非執行董事則包括李明華博士、姚海嵩先生和梅永康先生。委員會分別為審計委員會、薪酬與考核委員會、提名委員會以及戰略與發展委員會，各委員會成員的職位也在公告中得到確認。
Shanghai Micro-Chung Medical Robots (Group) Co., Ltd. (“Micro-Chao Robots”) announced on 29 December 2023 the list of Board members and their roles and functions in the four committees subordinate to the Board of Directors. THE EXECUTIVE DIRECTORS INCLUDE DR. HO CHAO AND THE NON-EXECUTIVE DIRECTORS ARE MR. SUN HUNG BIN, MR. CHAN XINXING AND MR. CHEN CHEN. The independent non-executive directors include Dr. Lee Minghua, Mr. Yao Haisong and Mr. Mei Yongkang. The committees are the Audit Committee, the Remuneration and Assessment Committee, the Nominating Committee and the Strategy and Development Committee. The positions of the members of the Committees are also confirmed in the announcement.
Shanghai Micro-Chung Medical Robots (Group) Co., Ltd. (“Micro-Chao Robots”) announced on 29 December 2023 the list of Board members and their roles and functions in the four committees subordinate to the Board of Directors. THE EXECUTIVE DIRECTORS INCLUDE DR. HO CHAO AND THE NON-EXECUTIVE DIRECTORS ARE MR. SUN HUNG BIN, MR. CHAN XINXING AND MR. CHEN CHEN. The independent non-executive directors include Dr. Lee Minghua, Mr. Yao Haisong and Mr. Mei Yongkang. The committees are the Audit Committee, the Remuneration and Assessment Committee, the Nominating Committee and the Strategy and Development Committee. The positions of the members of the Committees are also confirmed in the announcement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more